The majority of assisted reproductive technology (ART) program directors believe they have a responsibility to set selection criteria and screen infertile couples to ensure the safety and welfare of mother and child.
The majority of assisted reproductive technology (ART) program directors believe they have a responsibility to set selection criteria and screen infertile couples to ensure the safety and welfare of mother and child. But because most programs (72%) do not have a formal screening policy in place, they set their own screening guidelines-which vary widely across programs-according to a study in Fertility and Sterility (1/05).
When it comes to screening candidates, all 210 ART program directors who responded to an anonymous, self-administered questionnaire screened for physical health and age. Most programs collected information on drug use (98%), marital status (95%), HIV status (92%), and mental health (89%). A minority of programs considered religion (34%), criminal history (17%), and a home visit or evaluation (1%) in screening candidates.
When presented with hypothetical scenarios of possible candidates for ART and asked how likely respondents would be to turn away the candidates, the study's researchers found much variability across programs. For example, 46% of respondents said they would not likely turn away a couple on welfare, but 38% said they would be very or extremely likely to reject the couple. Similarly, 33% of respondents said they would not likely turn away a woman addicted to marijuana, but 47% said they would turn the woman away.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More